阿达木单抗治疗慢性活动性和有症状结节病患者的疗效。 - Suppr

Efficacy of adalimumab in chronically active and symptomatic patients with sarcoidosis.

作者信息

Kamphuis Lieke S, Lam-Tse Wai-Kwan, Dik Willem A, van Daele Paul L, van Biezen Paula, Kwekkeboom Dik J, Kuijpers Robert W, Hooijkaas Herbert, van Laar Jan A, Bastiaans Jeroen, Baarsma G Seerp, van Hagen P Martin

出版信息

Am J Respir Crit Care Med. 2011 Nov 15;184(10):1214-6. doi: 10.1164/ajrccm.184.10.1214.

DOI:10.1164/ajrccm.184.10.1214

PMID:22086995

Abstract

摘要

相似文献

Efficacy of adalimumab in chronically active and symptomatic patients with sarcoidosis.

Am J Respir Crit Care Med. 2011 Nov 15;184(10):1214-6. doi: 10.1164/ajrccm.184.10.1214.

Sarcoidosis and tocilizumab: is there a link?

Clin Exp Rheumatol. 2017 Jul-Aug;35(4):716. Epub 2017 May 15.

Adalimumab Induced Subcutaneous Nodular Sarcoidosis; A Rare Side Effect of Tumor Necrosis Factor-α Inhibitor.

Sarcoidosis Vasc Diffuse Lung Dis. 2014 Oct 20;31(3):249-51.

Sarcoidosis during therapy with adalimumab in a Crohn's disease patient: a paradoxical effect.

J Crohns Colitis. 2013 Dec;7(11):e599-600. doi: 10.1016/j.crohns.2013.06.002. Epub 2013 Jul 10.

Pulmonary sarcoidosis and latent tuberculosis in a patient with psoriasis treated with adalimumab.

Dermatol Online J. 2015 Jan 15;21(1):13030/qt95j8f3t4.

Effect of the TNF-α inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG-PET.

Clin Respir J. 2012 Oct;6(4):238-47. doi: 10.1111/j.1752-699X.2011.00276.x. Epub 2012 Feb 13.

[TNFα blocking agents and sarcoidosis: an update].

Rev Med Interne. 2010 Dec;31(12):828-37. doi: 10.1016/j.revmed.2010.02.007. Epub 2010 May 26.

Adalimumab for refractory pulmonary sarcoidosis.

Ir J Med Sci. 2016 Nov;185(4):969-971. doi: 10.1007/s11845-015-1363-9. Epub 2015 Oct 1.

Pulmonary sarcoidosis.

Clin Chest Med. 2004 Sep;25(3):521-30, vi. doi: 10.1016/j.ccm.2004.04.006.

Sarcoidosis complicating treatment with adalimumab for Crohn's disease.

J Crohns Colitis. 2014 Sep;8(9):1140-1. doi: 10.1016/j.crohns.2014.02.006. Epub 2014 Mar 13.

引用本文的文献

Cytokine Profiles of Bronchoalveolar Lavage in Patients with Interstitial Lung Diseases and Non-Allergic Asthma.

Int J Mol Sci. 2025 Jul 16;26(14):6831. doi: 10.3390/ijms26146831.

A review of sarcoidosis etiology, diagnosis and treatment.

Front Med (Lausanne). 2025 Feb 26;12:1558049. doi: 10.3389/fmed.2025.1558049. eCollection 2025.

Treatment of Granulomatous Inflammation in Pulmonary Sarcoidosis.

J Clin Med. 2024 Jan 27;13(3):738. doi: 10.3390/jcm13030738.

Emerging Therapeutic Options for Refractory Pulmonary Sarcoidosis: The Evidence and Proposed Mechanisms of Action.

J Clin Med. 2023 Dec 19;13(1):15. doi: 10.3390/jcm13010015.

Targeting the NLRP3 inflammasome and associated cytokines in scleroderma associated interstitial lung disease.

Front Cell Dev Biol. 2023 Oct 2;11:1254904. doi: 10.3389/fcell.2023.1254904. eCollection 2023.

The impact of demographic disparities in the presentation of sarcoidosis: A multicenter prospective study.

Respir Med. 2021 Oct;187:106564. doi: 10.1016/j.rmed.2021.106564. Epub 2021 Aug 9.

Treatment of Sarcoidosis: A Multidisciplinary Approach.

Front Immunol. 2020 Nov 19;11:545413. doi: 10.3389/fimmu.2020.545413. eCollection 2020.

Catch the rainbow: Prognostic factor of sarcoidosis.

Lung India. 2020 Sep-Oct;37(5):425-432. doi: 10.4103/lungindia.lungindia_380_19.

Clinical Manifestations, Diagnosis, and Treatment of Sarcoidosis.

Mayo Clin Proc Innov Qual Outcomes. 2019 Aug 2;3(3):358-375. doi: 10.1016/j.mayocpiqo.2019.04.006. eCollection 2019 Sep.

Development of Propionibacterium acnes-associated Sarcoidosis During Etanercept Therapy.

Intern Med. 2019 May 15;58(10):1473-1477. doi: 10.2169/internalmedicine.2086-18. Epub 2019 Jan 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Efficacy of adalimumab in chronically active and symptomatic patients with sarcoidosis.

Am J Respir Crit Care Med. 2011 Nov 15;184(10):1214-6. doi: 10.1164/ajrccm.184.10.1214.

Sarcoidosis and tocilizumab: is there a link?

Clin Exp Rheumatol. 2017 Jul-Aug;35(4):716. Epub 2017 May 15.

Adalimumab Induced Subcutaneous Nodular Sarcoidosis; A Rare Side Effect of Tumor Necrosis Factor-α Inhibitor.

Sarcoidosis Vasc Diffuse Lung Dis. 2014 Oct 20;31(3):249-51.

Sarcoidosis during therapy with adalimumab in a Crohn's disease patient: a paradoxical effect.

J Crohns Colitis. 2013 Dec;7(11):e599-600. doi: 10.1016/j.crohns.2013.06.002. Epub 2013 Jul 10.

Pulmonary sarcoidosis and latent tuberculosis in a patient with psoriasis treated with adalimumab.

Dermatol Online J. 2015 Jan 15;21(1):13030/qt95j8f3t4.

Effect of the TNF-α inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG-PET.

Clin Respir J. 2012 Oct;6(4):238-47. doi: 10.1111/j.1752-699X.2011.00276.x. Epub 2012 Feb 13.

[TNFα blocking agents and sarcoidosis: an update].

Rev Med Interne. 2010 Dec;31(12):828-37. doi: 10.1016/j.revmed.2010.02.007. Epub 2010 May 26.

Adalimumab for refractory pulmonary sarcoidosis.

Ir J Med Sci. 2016 Nov;185(4):969-971. doi: 10.1007/s11845-015-1363-9. Epub 2015 Oct 1.

Pulmonary sarcoidosis.

Clin Chest Med. 2004 Sep;25(3):521-30, vi. doi: 10.1016/j.ccm.2004.04.006.

Sarcoidosis complicating treatment with adalimumab for Crohn's disease.

J Crohns Colitis. 2014 Sep;8(9):1140-1. doi: 10.1016/j.crohns.2014.02.006. Epub 2014 Mar 13.

引用本文的文献

Cytokine Profiles of Bronchoalveolar Lavage in Patients with Interstitial Lung Diseases and Non-Allergic Asthma.

Int J Mol Sci. 2025 Jul 16;26(14):6831. doi: 10.3390/ijms26146831.

A review of sarcoidosis etiology, diagnosis and treatment.

Front Med (Lausanne). 2025 Feb 26;12:1558049. doi: 10.3389/fmed.2025.1558049. eCollection 2025.

Treatment of Granulomatous Inflammation in Pulmonary Sarcoidosis.

J Clin Med. 2024 Jan 27;13(3):738. doi: 10.3390/jcm13030738.

Emerging Therapeutic Options for Refractory Pulmonary Sarcoidosis: The Evidence and Proposed Mechanisms of Action.

J Clin Med. 2023 Dec 19;13(1):15. doi: 10.3390/jcm13010015.

Targeting the NLRP3 inflammasome and associated cytokines in scleroderma associated interstitial lung disease.

Front Cell Dev Biol. 2023 Oct 2;11:1254904. doi: 10.3389/fcell.2023.1254904. eCollection 2023.

The impact of demographic disparities in the presentation of sarcoidosis: A multicenter prospective study.

Respir Med. 2021 Oct;187:106564. doi: 10.1016/j.rmed.2021.106564. Epub 2021 Aug 9.

Treatment of Sarcoidosis: A Multidisciplinary Approach.

Front Immunol. 2020 Nov 19;11:545413. doi: 10.3389/fimmu.2020.545413. eCollection 2020.

Catch the rainbow: Prognostic factor of sarcoidosis.

Lung India. 2020 Sep-Oct;37(5):425-432. doi: 10.4103/lungindia.lungindia_380_19.

Clinical Manifestations, Diagnosis, and Treatment of Sarcoidosis.

Mayo Clin Proc Innov Qual Outcomes. 2019 Aug 2;3(3):358-375. doi: 10.1016/j.mayocpiqo.2019.04.006. eCollection 2019 Sep.

Development of Propionibacterium acnes-associated Sarcoidosis During Etanercept Therapy.

Intern Med. 2019 May 15;58(10):1473-1477. doi: 10.2169/internalmedicine.2086-18. Epub 2019 Jan 10.

Efficacy of adalimumab in chronically active and symptomatic patients with sarcoidosis.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献